1. Home
  2. KSS vs NBTX Comparison

KSS vs NBTX Comparison

Compare KSS & NBTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kohl's Corporation

KSS

Kohl's Corporation

SELL

Current Price

$22.04

Market Cap

1.9B

ML Signal

SELL

Logo Nanobiotix S.A.

NBTX

Nanobiotix S.A.

BUY

Current Price

$21.33

Market Cap

1.7B

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
KSS
NBTX
Founded
1962
2003
Country
United States
France
Employees
N/A
N/A
Industry
Department/Specialty Retail Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.9B
1.7B
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
KSS
NBTX
Price
$22.04
$21.33
Analyst Decision
Hold
Strong Buy
Analyst Count
14
5
Target Price
$18.88
★ $54.00
AVG Volume (30 Days)
★ 3.5M
140.1K
Earning Date
11-24-2026
09-24-2026
Dividend Yield
★ 2.36%
N/A
EPS Growth
★ 142.86
N/A
EPS
★ 1.18
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$0.04
$50.69
P/E Ratio
$17.92
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$11.38
$14.78
52 Week High
$25.22
$57.14

Technical Indicators

Market Signals
Indicator
KSS
NBTX
Relative Strength Index (RSI) 75.31 24.57
Support Level $16.19 $19.99
Resistance Level N/A $22.48
Average True Range (ATR) 0.89 1.50
MACD 0.33 -0.44
Stochastic Oscillator 99.32 5.10

Price Performance

Historical Comparison
KSS
NBTX

About KSS Kohl's Corporation

Kohl's is the second-largest traditional US department store company by sales. It has about 1,150 stores in 49 states and offers moderately priced private-label (31% of 2025 sales) and national brand clothing, shoes, accessories, cosmetics, and home furnishings. Most (about 80%) of its stores are in strip centers. Kohl's also has a large digital sales operation (29% of 2025 sales). Women's apparel is the retailer's largest category, having generated 24% of its 2025 sales. Kohl's is headquartered in Menomonee Falls, Wisconsin, and was founded in 1962.

About NBTX Nanobiotix S.A.

Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.

Share on Social Networks: